Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial (Q28277066)

4

object named as

D Easton

0 references

author name string

T Powles

1

0 references

S Ashley

3

0 references

J Chang

5

0 references

M Dowsett

6

0 references

A Tidy

7

0 references

J Viggers

8

0 references

J Davey

Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata

9

0 references

language of work or name

English

0 references

publication date

11 July 1998

0 references

published in

The Lancet

0 references

volume

352

0 references

issue

9122

0 references

page(s)

98-101

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Tamoxifen and contralateral breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Age at onset as an indicator of familial risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Tamoxifen therapy and carcinogenic risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

Association of BRCA1 with Rad51 in mitotic and meiotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2985012-5

7 January 2021

10.1016/S0140-6736(98)85012-5

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4778258

4778258

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference